Impact of Consumption of Orange-fleshed Sweet Potatoes on the Vitamin A Status of Bangladeshi Women of Reproductive Age
NCT ID: NCT00453648
Last Updated: 2017-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
130 participants
INTERVENTIONAL
2006-03-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fermented Iron-rich Supplement in Reducing Anemia
NCT02037724
Iron Bioavailability From Biofortified Orange-fleshed Sweet Potato
NCT03840031
Periconceptional Iron Supplementation in Rural Bangladesh
NCT00953134
Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh
NCT00198822
Effect of Iron Supplements on the Growth of Enteric Pathogens
NCT05762380
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. to assess the efficacy of daily consumption of boiled or fried orange-fleshed sweet potatoes (OFSP) for increasing the vitamin A status of non-pregnant, non-lactating Bangladeshi women, and
2. to estimate the relative vitamin A equivalency of beta-carotene from the two different preparations of OFSP (boiled or fried).
Secondary purposes are to assess the effect of daily consumption of OFSP on intestinal absorption of iron and zinc. Specifically, 120 non-pregnant, non-lactating women at risk of vitamin A deficiency will be randomly assigned to one of the following 4 treatment groups to receive, 600 micrograms RAE/d, 6 d/wk, for 60 days as either:
1. boiled OFSP
2. fried OFSP
3. retinyl palmitate, or 0 micrograms RAE/d as white-fleshed sweet potato (WFSP)
The paired stable isotope dilution technique will be used to estimate total body vitamin A pool size before and after 60-days of supplementation. The efficacy of consumption of OFSP will be assessed by comparing the mean change in vitamin A pool size in the OFSP groups to the mean change in vitamin A pool size in the negative control group (WFSP group). Relative vitamin A equivalency factors will be estimated by comparing the mean change in vitamin A pool size in the OFSP groups with the mean change in vitamin A pool size in the retinyl palmitate group. Intestinal iron absorption and iron status will be assessed before and after the 60-day supplementation period in a subset of women (n=50); and intestinal zinc absorption and zinc status will be assessed after the 60-day supplementation period (n=50). Intestinal absorption of iron and zinc will be compared by treatment group to determine whether consumption of OFSP has any effect on iron or zinc absorption in these women.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
White-fleshed Sweet Potato
0 ug retinol activity equivalents (RAE)/d as boiled white-fleshed sweet potatoes (WFSP) and a corn oil capsule, 6d/wk for 10 wk
White-fleshed sweet potatoes
Orange-fleshed Sweet Potato (boiled)
600 ug RAE/d as boiled orange-fleshed sweet potato and a corn oil capsule, 6d/wk for 10 wk
Orange-fleshed sweet potatoes (boiled)
Orange-fleshed Sweet Potato (fried)
600 ug RAE/d as fried orange-fleshed sweet potato and a corn oil capsule, 6d/wk for 10 wk
Orange-fleshed sweet potatoes (fried)
White-fleshed Sweet Potato and retinyl palmitate capsule
0 ug RAE/d as white-fleshed sweet potato and 600 ug retinol/d as retinyl palmitate, 6d/wk for 10 wk
WFSP and capsule of retinyl palmitate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
White-fleshed sweet potatoes
Orange-fleshed sweet potatoes (boiled)
Orange-fleshed sweet potatoes (fried)
WFSP and capsule of retinyl palmitate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Serum C-reactive protein concentration \< 10 mg/L
Exclusion Criteria
* Lactating
* Diarrhea within past week
* Severe anemia (\< 9g Hb/dL)
* Symptoms of nightblindness
* Clinical symptoms of xerophthalmia
* Chronic disease
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
International Centre for Diarrhoeal Disease Research, Bangladesh
OTHER
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marjorie J Haskell, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, Davis
Kenneth H Brown, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, Davis
Kazi Jamil, MBBS, PhD
Role: PRINCIPAL_INVESTIGATOR
International Centre for Diarrhoeal Disease Research, Bangladesh
References
Explore related publications, articles, or registry entries linked to this study.
Jamil KM, Brown KH, Jamil M, Peerson JM, Keenan AH, Newman JW, Haskell MJ. Daily consumption of orange-fleshed sweet potato for 60 days increased plasma beta-carotene concentration but did not increase total body vitamin A pool size in Bangladeshi women. J Nutr. 2012 Oct;142(10):1896-902. doi: 10.3945/jn.112.164830. Epub 2012 Aug 29.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Harvest Plus 8027
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
Harvest Plus 8033
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
200513770
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.